Hovione Eireann Revenue and Competitors
Estimated Revenue & Valuation
- Hovione Eireann's estimated annual revenue is currently $23.5M per year.
- Hovione Eireann's estimated revenue per employee is $201,000
Employee Data
- Hovione Eireann has 117 Employees.
- Hovione Eireann grew their employee count by 38% last year.
Hovione Eireann's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Senior Product Owner | Reveal Email/Phone |
2 | Founder / Chairman | Reveal Email/Phone |
3 | CEO | Reveal Email/Phone |
4 | Chief Information Officer | Reveal Email/Phone |
5 | SVP Sales & Marketing | Reveal Email/Phone |
6 | IT Officer | Reveal Email/Phone |
7 | VP Human Resources (CHRO) | Reveal Email/Phone |
8 | VP Sales | Reveal Email/Phone |
9 | VP Business Innovation | Reveal Email/Phone |
10 | VP Strategic Programs | Reveal Email/Phone |
Hovione Eireann Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $91.5M | 455 | 19% | N/A | N/A |
#2 | $19.3M | 96 | 5% | N/A | N/A |
#3 | $23.5M | 117 | 38% | N/A | N/A |
#4 | $60.3M | 300 | 46% | N/A | N/A |
#5 | $0.2M | 1 | 0% | N/A | N/A |
#6 | $14.3M | 71 | 16% | N/A | N/A |
What Is Hovione Eireann?
Hovione is an international company with over 55 years experience in the development and compliant manufacture of Active Pharmaceutical Ingredients and Drug Product Intermediates. With four FDA inspected sites in Portugal, the U.S., Ireland and China, Hovione offers integrated API, particle design, formulation development and GMP manufacturing. In the inhalation area, Hovione is the only independent company offering such a broad range of services.
keywords:Biotechnology,Healthcare,Pharmaceuticals
N/A
Total Funding
117
Number of Employees
$23.5M
Revenue (est)
38%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Hovione Eireann News
Employer authenticity is key to talent retention, say HR leaders Irish Examiner
CORK, Ireland, March 17, 2021 /PRNewswire/ -- Hovione announced at the Ophthalmology Innovation Summit (OIS) Dry Eye Showcase the successful completion of its Phase 2 clinical trial in 270 patients with Dry Eye caused by Meibomian Gland Dysfunction (MGD). The well controlled and representative s ...
The four new organisations are BT Ireland, the Central Bank, Heineken Ireland and Hovione Ireland. A further seven were recertified to the ...
Other Companies in Cork
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $24.3M | 121 | -2% | N/A |
#2 | N/A | 122 | 23% | N/A |
#3 | $35.4M | 122 | 3% | N/A |
#4 | $30M | 122 | 8% | N/A |
#5 | $43.8M | 124 | 27% | N/A |